435
Participants
Start Date
February 28, 2005
Primary Completion Date
August 31, 2005
Study Completion Date
August 31, 2005
GW679769
GSK Investigational Site, Manila
GSK Investigational Site, Manila
GSK Investigational Site, Budapest
GSK Investigational Site, Budapest
GSK Investigational Site, Slovenj Gradec
GSK Investigational Site, Glostrup Municipality
GSK Investigational Site, Szentes
GSK Investigational Site, Novo Mesto
GSK Investigational Site, Viborg
GSK Investigational Site, Bangkok
GSK Investigational Site, Bangkok
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Madrid
GSK Investigational Site, Pamplona
GSK Investigational Site, Melbourne
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Kfar Saba
GSK Investigational Site, Royal Oak
GSK Investigational Site, Grand Rapids
GSK Investigational Site, Tel Litwinsky
GSK Investigational Site, Chicago
GSK Investigational Site, Dallas
GSK Investigational Site, San Antonio
GSK Investigational Site, San Francisco
GSK Investigational Site, Seattle
GSK Investigational Site, Camden
GSK Investigational Site, Copenhagen
GSK Investigational Site, Lai Chi Kok
GSK Investigational Site, Pokfulam
GSK Investigational Site, Shamshuipo, Kowloon
GSK Investigational Site, Shatin, New Territories
GSK Investigational Site, Tuenmen
GSK Investigational Site, Gjettum
GSK Investigational Site, Oslo
GSK Investigational Site, Skien
GSK Investigational Site, Ljubljana
GSK Investigational Site, Badalona(Barcelona)
GSK Investigational Site, Barcelona
GSK Investigational Site, Glasgow
GSK Investigational Site, Glasgow
GSK Investigational Site, Glasgow
GSK Investigational Site, Edinburgh
GSK Investigational Site, Livingston
GSK Investigational Site, Hull
Lead Sponsor
GlaxoSmithKline
INDUSTRY